Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
8.55
+0.43 (5.30%)
At close: May 12, 2025, 4:00 PM
8.66
+0.11 (1.29%)
After-hours: May 12, 2025, 7:54 PM EDT
Intellia Therapeutics Analyst Ratings
Total Analysts
20
Consensus Rating
Buy
Price Target
$38.60
Upside
+351.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $55 → $45 | Strong Buy | Maintains | $55 → $45 | +426.32% | May 12, 2025 |
| Citigroup | Citigroup | Hold Maintains $14 → $10 | Hold | Maintains | $14 → $10 | +16.96% | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $68 | Strong Buy | Maintains | $68 | +695.32% | May 9, 2025 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $21 | Hold → Buy | Upgrades | $21 | +145.61% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +250.88% | Mar 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $90 → $50 | Strong Buy | Maintains | $90 → $50 | +484.80% | Mar 4, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $26 | Buy | Maintains | $55 → $26 | +204.09% | Feb 28, 2025 |
| Citigroup | Citigroup | Hold Maintains $12 → $14 | Hold | Maintains | $12 → $14 | +63.74% | Feb 28, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $60 → $50 | Buy | Maintains | $60 → $50 | +484.80% | Feb 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $91 → $68 | Strong Buy | Maintains | $91 → $68 | +695.32% | Feb 28, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $45 → $13 | Buy → Hold | Downgrades | $45 → $13 | +52.05% | Feb 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $56 → $11 | Buy → Hold | Downgrades | $56 → $11 | +28.65% | Jan 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $20 → $12 | Hold | Maintains | $20 → $12 | +40.35% | Jan 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $40 | Buy | Maintains | $60 → $40 | +367.84% | Jan 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $70 → $60 | Buy | Maintains | $70 → $60 | +601.75% | Jan 10, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $70 → $50 | Buy | Maintains | $70 → $50 | +484.80% | Jan 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.